Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Enrollment completed in phase IIa study of Serodus' SER-150

Nov. 28, 2016

RGC upregulation may have a pathogenic role in lupus nephritis

Nov. 24, 2016

Rayaldee set for U.S. launch

Nov. 24, 2016

LPA receptor 1 as a target for diabetic nephropathy

Nov. 24, 2016

Taisho Pharmaceutical's TP-0463518 in clinical development for renal anemia

Nov. 23, 2016

Regulus chemically modified oligonucleotide for Alport syndrome

Nov. 22, 2016

Sandoz's epoetin alfa biosimilar for renal anemia

Nov. 22, 2016

Pan-Nox inhibitor for diabetic nephropathy

Nov. 22, 2016

Laboratoris Sanifit reports clinical data on SNF-472

Nov. 21, 2016

Apricus plans for Vitaros NDA resubmission next year

Nov. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...